Lmito Therapeutics
Lmito Therapeutics Inc. is an innovation-driven biotech company with a novel therapy developed through the emerging concept of “metabolic reprogramming” – converting anabolic metabolism to catabolic metabolism in the various microenvironments.
The company has an improved process for robust IND generation platform technology, creating novel and effective therapies for multiple applications in various in vivo models of autoimmune disorders, fibrotic diseases, cancers, and neurological disorders.
- For more information, visit: https://www.lmito.com
